Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 16, 2022 17:00 ET | Source: Petros Pharmaceuticals, Inc.

Petros Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update

NEW YORK, May 16, 2022 (GLOBE NEWSWIRE) -- Petros Pharmaceuticals, Inc. (“Petros” or “the Company”) (Nasdaq: PTPI), a leading provider of therapeutics for men’s health, today announced financial...
May 12, 2022 08:13 ET | Source: Guardion Health Sciences, Inc.

Guardion Health Sciences Announces Financial Results for the Quarter Ended March 31, 2022

HOUSTON, May 12, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition company that offers a portfolio of science-based,...
May 11, 2022 16:15 ET | Source: BioCardia, Inc.

BioCardia Reports First Quarter 2022 Business Highlights and Financial Results

SUNNYVALE, Calif., May 11, 2022 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases,...
May 09, 2022 16:05 ET | Source: Atossa Therapeutics, Inc.

Atossa Therapeutics Announces First Quarter 2022 Financial Results and Provides Corporate Update

SEATTLE, May 09, 2022 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to develop innovative proprietary medicines in oncology and...
May 09, 2022 08:00 ET | Source: Alimera Sciences, Inc.

Alimera Sciences Reports First Quarter 2022 Results

Consolidated Net Revenue of $11.9 Million Up 6% vs. First Quarter of 2021U.S. Net Revenue Increased 23% vs. First Quarter of 2021U.S. End User Demand Up 25% vs. First Quarter of 2021 ATLANTA, May ...